Similar Search Results

Hospital Competition and Quality with Regulated Prices

Brekke, Kurt Richard - 2010

We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...

Persistent link: https://www.econbiz.de/10013152862

Reference Pricing with Endogenous Generic Entry

Brekke, Kurt Richard - 2015

. Allowing for price cap regulation, we show that the negative effect on generic entry can be reversed, and that reference …

Persistent link: https://www.econbiz.de/10013024341

Competition and Quality in Regulated Markets with Sluggish Demand

Brekke, Kurt Richard - 2010

We investigate the effect of competition on quality in regulated markets (e.g., health care, higher education, public utilities), using a Hotelling framework, in the presence of sluggish demand. We take a differential-game approach, and derive the open-loop solution (providers choose the optimal...

Persistent link: https://www.econbiz.de/10013148292

Price Regulation and Parallel Imports of Pharmaceuticals

Brekke, Kurt Richard - 2014

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. First … prices. We show that the effects of price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the pharmacy, price regulation counteracts this effect and …

Persistent link: https://www.econbiz.de/10013060442

Regulation and Pricing of Pharmaceuticals : Reference Pricing or Price Cap Regulation?

Brekke, Kurt Richard; Grasdal, Astrid; Holmas, Tor Helge - 2021

-patent pharmaceuticals, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel … dataset, covering the drugs exposed to RP and a large number of drugs still under PC regulation in the time before and after … regulation in lowering drug prices, while the cross-price effect raises a concern about patent protection …

Persistent link: https://www.econbiz.de/10013316907

Reference Pricing of Pharmaceuticals

Brekke, Kurt Richard; Königbauer, Ingrid; Straume, Odd Rune - 2021

We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...

Persistent link: https://www.econbiz.de/10013317373

Price Regulation and Parallel Imports of Pharmaceuticals

Brekke, Kurt Richard - 2015

This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a … that the effects of stricter price regulation crucially depend on whether the producer faces competition from parallel … imports. While parallel imports improve the bargaining position of the distributor, price regulation counteracts this effect …

Persistent link: https://www.econbiz.de/10013017702

Diffusion of Pharmaceuticals : Cross-Country Evidence of Anti-TNF Drugs

Brekke, Kurt Richard; Dalen, Dag Morten; Holmas, Tor Helge - 2013

This paper studies the diffusion of biopharmaceuticals across European countries, focusing on anti-TNF drugs, which are used to treat autoimmune diseases (e.g., rheumatism, psoriasis). We use detailed sales information on the three brands Remicade, Enbrel and Humira for nine European countries...

Persistent link: https://www.econbiz.de/10014158749

Quality competition with profit constraints: Do non-profit firms provide higher quality than for-profit firms?

Brekke, Kurt Richard; Siciliani, Luigi; Straume, Odd Rune - C.E.P.R. Discussion Papers - 2011

regulation or because they have non-profit status. At the same time such firms might have altruistic concerns towards consumers …

Persistent link: https://www.econbiz.de/10008865972

Margins and Market Shares: Pharmacy Incentives for Generic Substitution.

Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune - Institutt for samfunnsøkonomi, Norges Handelshøyskole … - 2010

We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that...

Persistent link: https://www.econbiz.de/10009019275